Although numerous studies revealed that CYP24A1 could act as a therapeutic target in cancers and the SNP of CYP24A1 was associated with increased cancer risk and poor prognosis [13,30,49,70,71], it was still unclear whether CYP24A1 expression was significantly related to drug resistance. Here, CYP24A1 is linked to cancer.